Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease-Reference-Cited by-同舟云学术

Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease

Published:1995-11 Issue:S6 Volume:15 Page:S70-S75
ISSN:0271-9142
Container-title:Journal of Clinical Immunology
language:en
Short-container-title:J Clin Immunol

Author:

Dalakas Marinos C.

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/BF01540896.pdf

Reference23 articles.

1. Dalakas MC: Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med 325:1487?1498, 1991

2. Dalakas MC: Inflammatory myopathies: Pathogenesis and treatment. Neuropharmacology 5:327?351, 1992

3. Dalakas MC (ed): Polymyositis and Dermatomyositis. Boston, Butterworths, 1988

4. Engel AG, Hanhfeld R, Banker BQ: The polymyositis and dermatomyositis syndrome.In Myology, Engel AG, Franzini-Armstrong C (eds). New York, McGraw-Hill, 1994, pp 1335?1383

5. Rowland LP: Dermatomyositis and polymyositis.In Merritt's Textbook of Neurology, Rowland LP (ed). Philadelphia, Lea & Febiger, 1984, pp 592A-592F

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with add-on IVIg in Myositis Early In the diSease course May be sUperior to Steroids alone for reaching CLinical improvEment (TIME IS MUSCLE): study protocol of a phase-2 double-blind placebo-controlled randomised trial;BMJ Open;2023-07

2. Europäische Leitlinien (S1) für die Verwendung von hoch dosierten intravenösen Immunglobulinen in der Dermatologie;Der Hautarzt;2020-05-20

3. Europäische Leitlinien (S1) für die Anwendung von hochdosierten intravenösen Immunglobulinen in der Dermatologie;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2017-02

4. European Guidelines (S1) on the use of high‐dose intravenous immunoglobulin in dermatology;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2016-12-30

5. European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology;Journal of the European Academy of Dermatology and Venereology;2016-07-13